ChemChina Completes The First Settlement Of The Tender Offers For Syngenta AG
Published: May 19, 2017
BASEL, Switzerland--(BUSINESS WIRE)--China National Chemical Corporation (ChemChina) today announced the successful completion of the First Settlement of ChemChina’s tender offers for Syngenta. Shareholders who tendered their shares by May 4, 2017 received the consideration of US$465 per share, and holders of American Depositary Shares ("ADSs") who tendered their ADSs received US$93 per ADS, on May 18, 2017. Shareholders who tender their shares or ADSs by the end of the Additional Acceptance Period on May 24, 2017 will receive the same consideration in the Second Settlement. The Second Settlement is expected to occur on June 7, 2017. In addition, a dividend of CHF 5 per share was paid to all shareholders on May 16, 2017.
The prospective timetable for the closing of the offers is as follows:
|Wednesday, May 24, 2017||End of the Additional Acceptance Period|
Friday, May 26, 2017
(at the latest)
|Provisional notice of the end result of the Offer|
|Wednesday, May 31, 2017||Definitive notice of the end result of the Offer|
|Wednesday, June 7, 2017||Second Settlement|
Further, as soon as permitted by law and applicable regulations, it is intended to de-list the shares from the SIX and to de-list the ADSs from the NYSE.
Syngenta is a leading agriculture company helping to improve global food security by enabling millions of farmers to make better use of available resources. Through world class science and innovative crop solutions, our 28,000 people in over 90 countries are working to transform how crops are grown. We are committed to rescuing land from degradation, enhancing biodiversity and revitalizing rural communities. To learn more visit www.syngenta.com and www.goodgrowthplan.com. Follow us on Twitter® at www.twitter.com/Syngenta.
ChemChina, which is headquartered in Beijing, China, possesses production, R&D and marketing systems in 150 countries and regions. It is the largest chemical corporation in China, and occupies the 234th position among the Fortune Global 500. The company’s main businesses include materials science, life science, high-end manufacturing and basic chemicals, among others. Previously, ChemChina has successfully acquired 9 leading industrial companies in France, United Kingdom, Israel, Italy and Germany, etc. To learn more visit www.chemchina.com and www.chemchina.com/press.
This press release is not an offer to purchase or a solicitation of an offer to sell any securities.
Additional information and where to find it
This press release is for informational purposes only and does not constitute an offer to purchase or a solicitation of an offer to sell company securities. The solicitation and offer to buy company securities is only made pursuant to the Swiss offer prospectus and the offer to purchase and other documents relating to the U.S. offer that have been filed with the US Securities and Exchange Commission (“SEC”). At the time the US Public Tender Offer was commenced, ChemChina and a designated direct or indirect subsidiary filed a tender offer statement on Schedule TO with the SEC and thereafter, the company filed a solicitation/recommendation statement on Schedule 14d-9 with respect to the offer. Investors and security holders are urged to read these materials carefully since they contain important information, including the terms and conditions of the offer. Investors and security holders may obtain a free copy of these materials and other documents filed by ChemChina and the company with the SEC at the website maintained by the SEC at www.sec.gov. Investors and security holders may also obtain free copies of the solicitation/recommendation statement and other documents filed with the SEC by the company at www.syngenta.com.
Cautionary statement regarding forward-looking statements
Some of the statements contained in this press release are forward-looking statements, including statements regarding the expected consummation of the acquisition, which involves a number of risks and uncertainties, including the possibility that the transaction will not be completed and other risks and uncertainties discussed in the company’s public filings with the SEC, including the “risk factors” section of the company’s form 20-F filed on February 16, 2017 as well as the tender offer documents filed by the offeror and the solicitation/recommendation statement filed by the company. These statements are based on current expectations, assumptions, estimates and projections, and involve known and unknown risks, uncertainties and other factors that may cause results, levels of activity, performance or achievements to be materially different from any forward-looking statements. These statements are generally identified by words or phrases such as “believe”, “anticipate”, “expect”, “intend”, “plan”, “will”, “may”, “should”, “estimate”, “predict”, “potential”, “continue” or the negative of such terms or other similar expressions. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results and the timing of events may differ materially from the results and/or timing discussed in the forward-looking statements, and you should not place undue reliance on these statements. The offeror, ChemChina and the company disclaim any intent or obligation to update any forward-looking statements as a result of developments occurring after the period covered by this press release or otherwise.
Syngenta International AG
Tel: +41 61 323 2323
Fax: +41 61 323 2424
Switzerland +41 61 323 2323
USA +1 202 737 8913
Switzerland +41 61 323 5059
USA +1 202 737 6521